Literature DB >> 32393674

Efficient genome editing by CRISPR-Mb3Cas12a in mice.

Zhuqing Wang1, Yue Wang1, Shawn Wang1, Andrew J Gorzalski2, Hayden McSwiggin1, Tian Yu1, Kimberly Castaneda-Garcia1, Brian Prince1, Hetan Wang1, Huili Zheng1, Wei Yan3,4,5.   

Abstract

As an alternative and complementary approach to Cas9-based genome editing, Cas12a has not been widely used in mammalian cells largely due to its strict requirement for the TTTV protospacer adjacent motif (PAM) sequence. Here, we report that Mb3Cas12a (Moraxella bovoculi AAX11_00205) can efficiently edit the mouse genome based on the TTV PAM sequence with minimal numbers of large on-target deletions or insertions. When TTTV PAM sequence-targeting CRISPR (cr)RNAs of 23 nt spacers are used, >70% of the founders obtained are edited. Moreover, the use of Mb3Cas12a tagged to monomeric streptavidin (mSA) in conjunction with biotinylated DNA donor template leads to high knock-in efficiency in two-cell mouse embryos, with 40% of founders obtained containing the desired knock-in sequences.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  CRISPR; Cas12a; Cas9; Cpf1; Genome editing; PAM

Year:  2020        PMID: 32393674      PMCID: PMC7240296          DOI: 10.1242/jcs.240705

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  27 in total

1.  Efficient generation of targeted large insertions by microinjection into two-cell-stage mouse embryos.

Authors:  Bin Gu; Eszter Posfai; Janet Rossant
Journal:  Nat Biotechnol       Date:  2018-06-11       Impact factor: 54.908

2.  Large deletions induced by Cas9 cleavage.

Authors:  Fatwa Adikusuma; Sandra Piltz; Mark A Corbett; Michelle Turvey; Shaun R McColl; Karla J Helbig; Michael R Beard; James Hughes; Richard T Pomerantz; Paul Q Thomas
Journal:  Nature       Date:  2018-08-08       Impact factor: 49.962

3.  The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.

Authors:  Ines Fonfara; Hagen Richter; Majda Bratovič; Anaïs Le Rhun; Emmanuelle Charpentier
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962

4.  In vivo high-throughput profiling of CRISPR-Cpf1 activity.

Authors:  Hui K Kim; Myungjae Song; Jinu Lee; A Vipin Menon; Soobin Jung; Young-Mook Kang; Jae W Choi; Euijeon Woo; Hyun C Koh; Jin-Wu Nam; Hyongbum Kim
Journal:  Nat Methods       Date:  2016-12-19       Impact factor: 28.547

5.  Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.

Authors:  Michael Kosicki; Kärt Tomberg; Allan Bradley
Journal:  Nat Biotechnol       Date:  2018-07-16       Impact factor: 54.908

6.  High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.

Authors:  Yanfang Fu; Jennifer A Foden; Cyd Khayter; Morgan L Maeder; Deepak Reyon; J Keith Joung; Jeffry D Sander
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

7.  X-linked miR-506 family miRNAs promote FMRP expression in mouse spermatogonia.

Authors:  Zhuqing Wang; Yeming Xie; Yue Wang; Dayton Morris; Shawn Wang; Daniel Oliver; Shuiqiao Yuan; Kathleen Zayac; Savanah Bloomquist; Huili Zheng; Wei Yan
Journal:  EMBO Rep       Date:  2019-12-06       Impact factor: 9.071

8.  Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.

Authors:  Bernd Zetsche; Matthias Heidenreich; Prarthana Mohanraju; Iana Fedorova; Jeroen Kneppers; Ellen M DeGennaro; Nerges Winblad; Sourav R Choudhury; Omar O Abudayyeh; Jonathan S Gootenberg; Wen Y Wu; David A Scott; Konstantin Severinov; John van der Oost; Feng Zhang
Journal:  Nat Biotechnol       Date:  2016-12-05       Impact factor: 54.908

9.  Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.

Authors:  Alexander A Sousa; Russell T Walton; Benjamin P Kleinstiver; Y Esther Tak; Jonathan Y Hsu; Kendell Clement; Moira M Welch; Joy E Horng; Jose Malagon-Lopez; Irene Scarfò; Marcela V Maus; Luca Pinello; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2019-02-11       Impact factor: 68.164

10.  A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells.

Authors:  Mengjun Tu; Li Lin; Yilu Cheng; Xiubin He; Huihui Sun; Haihua Xie; Junhao Fu; Changbao Liu; Jin Li; Ding Chen; Haitao Xi; Dongyu Xue; Qi Liu; Junzhao Zhao; Caixia Gao; Zongming Song; Jia Qu; Feng Gu
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

View more
  5 in total

1.  Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition.

Authors:  Jin Zhou; Peng Chen; Hongjian Wang; Huan Liu; Yongzheng Li; Youpeng Zhang; Yankang Wu; Chonil Paek; Zaiqiao Sun; Jun Lei; Lei Yin
Journal:  Mol Ther       Date:  2021-10-20       Impact factor: 11.454

2.  Uncoupling transcription and translation through miRNA-dependent poly(A) length control in haploid male germ cells.

Authors:  Mei Guo; Chunhai Luo; Zhuqing Wang; Sheng Chen; Dayton Morris; Fengying Ruan; Zhichao Chen; Linfeng Yang; Xiongyi Wei; Chuanwen Wu; Bei Luo; Zhou Lv; Jin Huang; Dong Zhang; Cong Yu; Qiang Gao; Hongqi Wang; Ying Zhang; Fei Sun; Wei Yan; Chong Tang
Journal:  Development       Date:  2022-06-16       Impact factor: 6.862

3.  Ablation of the miR-465 Cluster Causes a Skewed Sex Ratio in Mice.

Authors:  Zhuqing Wang; Nan Meng; Yue Wang; Tong Zhou; Musheng Li; Shawn Wang; Sheng Chen; Huili Zheng; Shuangbo Kong; Haibin Wang; Wei Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-23       Impact factor: 6.055

Review 4.  A most formidable arsenal: genetic technologies for building a better mouse.

Authors:  James F Clark; Colin J Dinsmore; Philippe Soriano
Journal:  Genes Dev       Date:  2020-10-01       Impact factor: 11.361

5.  High-Throughput Profiling of Cas12a Orthologues and Engineered Variants for Enhanced Genome Editing Activity.

Authors:  Dan Zhu; Junyi Wang; Di Yang; Jianzhong Xi; Juan Li
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.